Labroots’ virtual events are a fantastic way to network and learn about the work of other researchers in your field. These events feature participants from around the world who can showcase their ...
The FDA’s accelerated approval pathway has a potentially prominent champion — Robert Califf, the scientist President Biden has nominated to lead the FDA. This pathway opens the door to earlier ...
The use of high-value clinical pathways combined with regular, data-driven peer discussions can slow drug costs in community oncology practice, according to new findings. Cancer Care Specialists of ...
Reducing drug spend is one of the greatest challenges for practices participating in the Oncology Care Model (OCM). Evidence-based clinical pathways have the potential to decrease drug spend while ...
Payers have exhausted traditional oncology benefit management options. Many of their strategies to control utilization have led to unintended consequences, such as driving poor utilization over to the ...
Global agencies have collaborated to create parallel regulatory approval solutions to help get drugs to patients more quickly. Experts who have used these schemes say that while these schemes have ...
The rapid worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created an urgent need for effective therapeutics to contain the ongoing coronavirus disease 2019 ...
During my years as a Food and Drug Administration official, I learned that the available data on a new drug are seldom as complete and unequivocal as you might like. But getting drugs to patients can ...
Reducing drug spend is one of the greatest challenges for practices participating in the Oncology Care Model (OCM). Evidence-based clinical pathways have the potential to decrease drug spend while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results